CSL Limited Receives “Buy” Rating from Deutsche Bank (CSL)
CSL Limited (ASX:CSL)‘s stock had its “buy” rating reiterated by stock analysts at Deutsche Bank in a report issued on Monday, Analyst RN reports. They currently have a $78.00 price target on the stock.
Shares of CSL Limited (ASX:CSL) opened at 69.200 on Monday. CSL Limited has a 1-year low of A$56.000 and a 1-year high of A$71.200. The stock’s 50-day moving average is A$69.08 and its 200-day moving average is A$67.31. The company has a market cap of A$33.501 billion and a P/E ratio of 26.89.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Friday, January 24th. They now have a $74.55 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. CSL Limited currently has a consensus rating of “Buy” and an average price target of A$73.76 ($67.06).
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.